Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study.

GlobalSurg Collaborative. · 2018

Read Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study. by GlobalSurg Collaborative. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5910057.txt.

Introduction

The GlobalSurg Collaborative tracked wound infections after gut operations across the world. Their cohort study appeared in The Lancet Infectious Diseases. Data came from 12,539 patients at 343 hospitals in 66 countries. Each country was classed as high, middle, or low income. Cases covered both planned and urgent gut resections. The team counted infections within thirty days of surgery.

About one patient in eight developed such an infection, they report. Low-income countries bore far more cases than rich ones. Contaminated operations posed the greatest danger everywhere. Germs that resisted the preventive antibiotic were also commoner in poorer settings. Adjusted risk stayed highest for low-income patients. The authors call for prevention work aimed where need is greatest.

Catalog record

CREATORGlobalSurg Collaborative.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5910057

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study Published in: The Lancet. Infectious Diseases DOI: 10.1016/S1473-3099(18)30101-4 ABSTRACT Summary Background Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p<0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p<0·001). Interpretation Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication. Funding DFID-MRC-Wellcome Trust Joint Global Health Trial Development Grant, National Institute of Health Research Global Health Research Unit Grant. INTRODUCTION Surgical site infection (SSI) is a large health burden for patients and health-care providers. It is the most common postoperative complication and causes pain and suffering to patients.1, 2 SSI is universally expensive3 and could result in catastrophic health expenditure and impoverishment to patients who are required to pay for their own treatment.4 In low-income and middle-income countries (LMICs), single-centre retrospective series have suggested that SSI could be the most common infection associated with health care.1 However, prospective, standardised, and internationally comparable data on the incidence of SSI and adverse events associated with SSI are lacking.5, 6, 7, 8 These knowledge gaps make allocation of resources to tackle SSI in LMICs challenging. The WHO Guideline Development Group recently published 29 preoperative, intraoperative, and postoperative recommendations about SSI prevention.6, 9, 10 These recommendations are welcomed but are necessarily based in large part on data extrapolated from high-income countries and, consequently, might lack validity in resource-limited settings. Strategic planning to tackle SSI has been hindered by a lack of high-quality global data. Microbiological data describing antimicrobial resistance in SSI and information on the likely origin of causative organisms are also needed to help refine prevention strategies and quality-improvement interventions.6, 10 Research in contextEvidence before this studyWe searched for evidence of multinational research assessing surgical site infection (SSI) after abdominal surgery, focusing on low-income and middle-income countries (LMICs). We searched PubMed, MEDLINE, Google Scholar, and ClinicalTrials.gov for articles published between Jan 1, 1997, and June 1, 2017, with the terms “wound infection” OR “surgical site infection” AND “developing countries” OR “low income” OR “middle income” OR “low and middle income”, without language restrictions. We reviewed related articles, references, and citations of eligible texts. Several low-volume, single-centre studies to characterise SSI in LMICs have been done in the past 20 years, but the research quality is low to medium. These studies were systematically reviewed in 2011 and included 57 studies of abdominal surgery, with reported SSI incidence ranging from 0·4% to 30·9% (between 1·5% and 81·0% for clean–contaminated surgery, 0·5% to 65·5% for contaminated surgery, and 0·2% to 100% for dirty surgery). The methodological quality of individual studies was low and heterogeneity was high, preventing meta-analysis. One multinational study has been done since 2010, and included patients from seven high-income, 17 upper-middle-income, and six lower-middle-income countries. The low observed SSI incidence (4·1%) after abdominal surgery could relate to the passive 30-day follow-up strategy; additional limitations include a lack of data from lowest-income countries and exclusion of children.Added value of this studyWe identified the burden and clinical impact of SSI in patients undergoing gastrointestinal surgery in multiple income settings. We used standardised, validated, prospective methodology to provide global, contemporaneous data. SSI is most common after dirty surgery in LMICs. Even after casemix adjustment, patients in LMICs have a disproportionate burden of infection. A large proportion of SSIs are caused by organisms resistant to prophylactic antibiotics with the greatest apparent burden in LMICs.Implications of all the available evidenceThe burden of SSI is disproportionately greater on patients and health services in LMICs. Recent WHO recommendations onpreoperative and intraoperative measures for SSI prevention highlight an absence of high-quality evidence. Urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication and associated antibiotic use. The GlobalSurg Collaborative designed and conducted an international, multicentre, prospective cohort study aimed at closing knowledge gaps in the incidence of SSI in global health settings. The primary aim was to determine variability in SSI rates in high-income, middle-income, and low-income settings. METHODS Study design and participants This international, multicentre, prospective cohort study used a published protocol11 and was done by teams of local investigators who were coordinated by a national lead investigator. Investigators were recruited via the GlobalSurg network, social media, and personal contacts. Any health-care facility in any country treating patients who fulfilled the inclusion criteria could participate. The collaborative network methodology has been described in detail elsewhere.12 Ethical and institutional approval was sought and obtained by each contributing institution as per local regulations. A UK National Health Service Research Ethics review considered this study exempt from formal research registration (South East Scotland Research Ethics Service, reference NR/1510AB5). Individual centres obtained their own audit or institutional approval, and ethical approval was

Read the complete text